supp.fit
All Berberine study protocols

Berberine and Policosanol: study protocols

9 study groups took Berberine together with Policosanol. These are the doses the studies gave. They are not a recommendation.

Berberine: what the research found →

Dose per serving from research: Berberine

9 study groups in 7 studies say how much Berberine participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 250 mg to 500 mg, 100% of 9 study groups.

Daily doseStudy groups
250 mg to 500 mg
9

Dose per serving from research: Policosanol

9 study groups in 7 studies say how much Policosanol participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 5 mg to 10 mg, 100% of 9 study groups.

Daily doseStudy groups
5 mg to 10 mg
9

Commonly used together

9 of 9 study groups took Berberine and Policosanol with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Red Yeast Rice
8
Coenzyme Q10
5
Folic Acid
5
Astaxanthin
4

9 study groups

Study
Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment
2012 · BBR/P/RR monotherapy · Adults with primary polygenic hypercholesterolemia who were statin-intolerant or declined statin treatment
500 mg10 mg180 days152
Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment
2012 · Supplementary BBR/P/RR in HeFH patients on stable statin treatment or statin plus ezetimibe · Adults with genotype-confirmed heterozygous familial hypercholesterolemia on stable-dose statins or statins plus ezetimibe
500 mg10 mg90 days30
Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment
2012 · Combined BBR/P/RR plus ezetimibe therapy · Adults with primary hypercholesterolemia selected for a low response to monotherapy
500 mg10 mg90 days26
Effects of a new combination of nutraceuticals with Morus alba on lipid profile, insulin sensitivity and endotelial function in dyslipidemic subjects. A cross-over, randomized, double-blind trial
2015 · Combination A · Adults aged 18–70 with hypercholesterolemia not requiring statins or statin-intolerant
500 mg10 mg4 weeks23
Effect of a food supplement containing berberine, monacolin K, hydroxytyrosol and coenzyme Q(10) on lipid levels: a randomized, double-blind, placebo controlled study
2017 · Armolipid Plus (AM) · Adults aged 18–75, both sexes, with mild-to-moderate hypercholesterolemia
500 mg10 mg4 weeks—
Efficacy of a nutraceutical combination on lipid metabolism in patients with metabolic syndrome: a multicenter, double blind, randomized, placebo controlled trial
2019 · Armolipid Plus (AP) · Adults aged 18–70 with metabolic syndrome and left ventricular hypertrophy; men and women
500 mg10 mg24 weeks71
Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study
2010 · nutraceutical combination (NC) · Adults with hypercholesterolemia; mean age 55 years; 26 males and 24 females were randomized across both arms
500 mg10 mg10 weeks25
Effects of poly-bioactive compounds on lipid profile and body weight in a moderately hypercholesterolemic population with low cardiovascular disease risk: a multicenter randomized trial
2014 · Intervention (Armolipid Plus/AP) · Men and women older than 18 years with mild-moderate hypercholesterolemia and elevated LDL-c, candidates for lifestyle intervention without hypolipemic drug treatment
500 mg10 mg12 weeks51
Effects of a New Combination of Medical Food on Endothelial Function and Lipid Profile in Dyslipidemic Subjects: A Pilot Randomized Trial
2019 · Nutraceutical B · Adults aged 18–75 with elevated serum cholesterol not requiring statins or statin-intolerant; people with cardiovascular disease and uncontrolled diabetes were excluded.
500 mg10 mg6 weeks23
Berberine and Policosanol: study protocols | supp.fit